276 related articles for article (PubMed ID: 27646951)
21. Surgical Disparities Among Patients With Stage I Lung Cancer in the National Lung Screening Trial.
Balekian AA; Wisnivesky JP; Gould MK
Chest; 2019 Jan; 155(1):44-52. PubMed ID: 30056040
[TBL] [Abstract][Full Text] [Related]
22. Trends in treatment and relative survival among Non-Small Cell Lung Cancer patients in the Netherlands (1990-2014): Disparities between younger and older patients.
Driessen EJ; Aarts MJ; Bootsma GP; van Loon JG; Janssen-Heijnen ML
Lung Cancer; 2017 Jun; 108():198-204. PubMed ID: 28625635
[TBL] [Abstract][Full Text] [Related]
23. Disparities in patient enrollment on glioblastoma clinical trials.
Liu Y; Wasilewski A; Mohile NA
CNS Oncol; 2020 Jun; 9(2):CNS59. PubMed ID: 32603616
[No Abstract] [Full Text] [Related]
24. Descriptive epidemiology of pituitary tumors in the United States, 2004-2009.
Gittleman H; Ostrom QT; Farah PD; Ondracek A; Chen Y; Wolinsky Y; Kruchko C; Singer J; Kshettry VR; Laws ER; Sloan AE; Selman WR; Barnholtz-Sloan JS
J Neurosurg; 2014 Sep; 121(3):527-35. PubMed ID: 24926650
[TBL] [Abstract][Full Text] [Related]
25. Inequalities in lung cancer care of elderly patients with schizophrenia: an observational cohort study.
Bergamo C; Sigel K; Mhango G; Kale M; Wisnivesky JP
Psychosom Med; 2014 Apr; 76(3):215-20. PubMed ID: 24677164
[TBL] [Abstract][Full Text] [Related]
26. Do Current Lung Cancer Clinical Trials Represent All Patient Populations Including Minorities?
Nemala A; Ullah A; Yacur M; Karim NA
Clin Lung Cancer; 2023 Nov; 24(7):573-580. PubMed ID: 37574437
[TBL] [Abstract][Full Text] [Related]
27. Trends in lung cancer incidence rates, Oklahoma 2005-2010.
Mowls DS; McCaffree DR; Beebe LA
PLoS One; 2015; 10(4):e0119251. PubMed ID: 25901351
[TBL] [Abstract][Full Text] [Related]
28. A surveillance system for monitoring, public reporting, and improving minority access to cancer clinical trials.
Carpenter WR; Tyree S; Wu Y; Meyer AM; DiMartino L; Zullig L; Godley PA
Clin Trials; 2012 Aug; 9(4):426-35. PubMed ID: 22761398
[TBL] [Abstract][Full Text] [Related]
29. Disparities in older adult accrual to cancer trials: Analysis from the alliance for clinical trials in oncology (A151736).
VanderWalde NA; Dockter T; Wakefield DV; Satele D; Sloan J; Jagsi R; Lichtman SM; Freedman RA; Lafky JM; Muss H; Cohen HJ; Le-Rademacher J; Jatoi A
J Geriatr Oncol; 2022 Jan; 13(1):20-26. PubMed ID: 34364834
[TBL] [Abstract][Full Text] [Related]
30. Disparities in lung cancer survival and receipt of surgical treatment.
Osuoha CA; Callahan KE; Ponce CP; Pinheiro PS
Lung Cancer; 2018 Aug; 122():54-59. PubMed ID: 30032845
[TBL] [Abstract][Full Text] [Related]
31. Barriers to enrollment in non-small cell lung cancer therapeutic clinical trials.
Baggstrom MQ; Waqar SN; Sezhiyan AK; Gilstrap E; Gao F; Morgensztern D; Govindan R
J Thorac Oncol; 2011 Jan; 6(1):98-102. PubMed ID: 21150469
[TBL] [Abstract][Full Text] [Related]
32. Ten-Year Trends in Enrollment of Women and Minorities in Pivotal Trials Supporting Recent US Food and Drug Administration Approval of Novel Cardiometabolic Drugs.
Khan MS; Shahid I; Siddiqi TJ; Khan SU; Warraich HJ; Greene SJ; Butler J; Michos ED
J Am Heart Assoc; 2020 Jun; 9(11):e015594. PubMed ID: 32427023
[TBL] [Abstract][Full Text] [Related]
33. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
34. National Trends and Disparities in Mammography Among Commercially Insured Women, 2001-2010.
Wharam JF; Landon BE; Xu X; Zhang F; Ross-Degnan D
J Public Health Manag Pract; 2015; 21(5):426-32. PubMed ID: 26214535
[TBL] [Abstract][Full Text] [Related]
35. Identifying barriers associated with enrollment of patients with lung cancer into clinical trials.
Horn L; Keedy VL; Campbell N; Garcia G; Hayes A; Spencer B; Carbone DP; Sandler A; Johnson DH
Clin Lung Cancer; 2013 Jan; 14(1):14-8. PubMed ID: 22591607
[TBL] [Abstract][Full Text] [Related]
36. Outcome disparities in colorectal cancer: a SEER-based comparative analysis of racial subgroups.
Al-Husseini MJ; Saad AM; Jazieh KA; Elmatboly AM; Rachid A; Gad MM; Ruhban IA; Hilal T
Int J Colorectal Dis; 2019 Feb; 34(2):285-292. PubMed ID: 30443675
[TBL] [Abstract][Full Text] [Related]
37. Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis.
Subramanian J; Morgensztern D; Goodgame B; Baggstrom MQ; Gao F; Piccirillo J; Govindan R
J Thorac Oncol; 2010 Jan; 5(1):23-8. PubMed ID: 19934774
[TBL] [Abstract][Full Text] [Related]
38. Treatment and survival disparities in lung cancer: the effect of social environment and place of residence.
Johnson AM; Hines RB; Johnson JA; Bayakly AR
Lung Cancer; 2014 Mar; 83(3):401-7. PubMed ID: 24491311
[TBL] [Abstract][Full Text] [Related]
39. Disparities in clinical trial enrollment among patients with gastrointestinal cancer relative to minority-serving and safety-netting hospitals.
Khan MMM; Munir MM; Woldesenbet S; Khalil M; Endo Y; Katayama E; Altaf A; Dillhoff M; Obeng-Gyasi S; Pawlik TM
J Gastrointest Surg; 2024 Jun; 28(6):896-902. PubMed ID: 38555017
[TBL] [Abstract][Full Text] [Related]
40. Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis.
Berry MF; Canchola AJ; Gensheimer MF; Gomez SL; Cheng I
Clin Lung Cancer; 2018 Sep; 19(5):e745-e758. PubMed ID: 30149883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
